CD14 and idiopathic pulmonary fibrosis: We identified two immunophenotypes associated with increased IPF risk (Figure S4): PDL‐1 on CD14+ CD16− monocyte (OR = 1.13, 95% CI = 1.00–1.27, p = 0.047) and PDL‐1 on CD14− CD16− (OR = 1.07, 95% CI = 1.01–1.14, p = 0.034).